Registrar Corp Registrar Corp LinkedIn Registrar Corp Twitter Registrar Corp Facebook Registrar Corp Google+ Registrar Corp Youtube Channel Registrar Corp FDA News Blog
HomeDrugsU.S. FDA Active Pharmaceutical Ingredients (API)API Examples › U.S. FDA Regulations: Ranitidine

U.S. FDA Requirements: Ranitidine

Pharmaceutical / Drug Definition : Inhibits histamine at H2 receptor sites in parietal cells, which inhibit gastric acid secretion

Registrar Corp assists Ranitidine companies with:

  • FDA Registration Ranitidine
  • FDA Listing Ranitidine
  • FDA Label Requirements and Exceptions Ranitidine
  • FDA Import Information Ranitidine
  • FDA Detentions Ranitidine (Ranitidine Entry Refusal)
  • General U.S. Food and Drug Administration Guidelines for:
       - Manufacturers Ranitidine (Ranitidine Suppliers)
       - Processors Ranitidine
       - Repackers Ranitidine
       - Relabelers Ranitidine
       - Exporters Ranitidine
       - Importers Ranitidine
For more information about Ranitidine, simply click below:




Live Help

 
U.S. FDA Regulations:

U.S. FDA Regulation: 21 C.F.R. Part 207


Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
Home | About Us | News | Resources | Exhibitions | Seminars | Associations | Careers | Sitemap | Terms of Use © 2014 Registrar Corp
 
Food and Beverages | Drugs | Cosmetics | Medical Devices | Radiation-Emitting Electronic Devices | Color Additives | Tobacco